209 related articles for article (PubMed ID: 8264878)
1. Ventriculolumbar perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosou rea hydrochloride.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Seto H; Uemura S; Ushio Y
Neurosurgery; 1993 Nov; 33(5):817-23. PubMed ID: 8264878
[TBL] [Abstract][Full Text] [Related]
2. Ventriculolumber perfusion of 3-[(4-amino-2-methyl-5-pyrimidinyl)-methyl]-1-(2-chloroethyl-1-nitrosou rea hydrochloride for subarachnoid dissemination of gliomas.
Ushio Y; Kochi M; Kitamura I; Kuratsu J
J Neurooncol; 1998; 38(2-3):207-12. PubMed ID: 9696373
[TBL] [Abstract][Full Text] [Related]
3. Neurotoxicity and pharmacokinetics of intrathecal perfusion of ACNU in dogs.
Kochi M; Kuratsu J; Mihara Y; Takaki S; Inoue N; Sueyoshi N; Uemura S; Ushio Y
Cancer Res; 1990 May; 50(10):3119-23. PubMed ID: 2334907
[TBL] [Abstract][Full Text] [Related]
4. [Intrathecal perfusion of ACNU neurotoxicity and intrathecal pharmacokinetics in dogs].
Kochi M; Kuratsu J; Mihara Y; Inoue N; Takaki S; Sueyoshi N; Soyama N; Uemura S; Ushio Y
No Shinkei Geka; 1989 Aug; 17(8):741-6. PubMed ID: 2586715
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of intrathecal 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride in rats.
Huang TY; Arita N; Ushio Y; Hayakawa T; Yamada K
J Neurooncol; 1994; 19(3):245-50. PubMed ID: 7807175
[TBL] [Abstract][Full Text] [Related]
6. Distribution of intrathecally administered ACNU in mongrel dogs: pharmacokinetics and quantitative autoradiographic study.
Hori T; Tanaka S; Nishiyama M; Kamitani H; Watanabe T; Tabuchi F; Tatsuhara T; Nakajima E
Surg Neurol; 1993 Sep; 40(3):183-95. PubMed ID: 8346472
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal mafosfamide therapy for pediatric brain tumors with meningeal dissemination.
Slavc I; Schuller E; Czech T; Hainfellner JA; Seidl R; Dieckmann K
J Neurooncol; 1998; 38(2-3):213-8. PubMed ID: 9696374
[TBL] [Abstract][Full Text] [Related]
8. Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia.
Levin VA; Chamberlain M; Silver P; Rodriguez L; Prados M
Cancer Chemother Pharmacol; 1989; 23(5):301-7. PubMed ID: 2706735
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of convection-enhanced delivery of ACNU, a hydrophilic nitrosourea, in intracranial brain tumor models.
Sugiyama S; Yamashita Y; Kikuchi T; Saito R; Kumabe T; Tominaga T
J Neurooncol; 2007 Mar; 82(1):41-7. PubMed ID: 17031554
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cytosine arabinoside, methotrexate, nimustine and valproic acid in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
Morikawa N; Mori T; Abe T; Kawashima H; Takeyama M; Hori S
Biol Pharm Bull; 2000 Jun; 23(6):784-7. PubMed ID: 10864038
[TBL] [Abstract][Full Text] [Related]
11. [Intrathecal infusion of the antineoplastic agents for meningeal dissemination].
Hodozuka A; Hayashi Y; Annei R; Hiroshima S; Saito M; Orimoto R; Sato M; Tanaka T
Gan To Kagaku Ryoho; 2008 Jun; 35(6):900-5. PubMed ID: 18633217
[TBL] [Abstract][Full Text] [Related]
12. Enhanced antitumor effect of combined-modality treatment using convection-enhanced delivery of hydrophilic nitrosourea with irradiation or systemic administration of temozolomide in intracranial brain tumor xenografts.
Sugiyama S; Yamashita Y; Kikuchi T; Sonoda Y; Kumabe T; Tominaga T
Neurol Res; 2008 Nov; 30(9):960-7. PubMed ID: 18671903
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of nimustine, methotrexate, and cytosine arabinoside during cerebrospinal fluid perfusion chemotherapy in patients with disseminated brain tumors.
Morikawa N; Mori T; Kawashima H; Fujiki M; Abe T; Kaku T; Konisi Y; Takeyama M; Hori S
Eur J Clin Pharmacol; 1998 Jul; 54(5):415-20. PubMed ID: 9754986
[TBL] [Abstract][Full Text] [Related]
14. Intrathecal chemotherapy with ACNU in a meningeal gliomatosis rat model.
Yoshida TK; Shimizu K; Koulousakis A; Sturm V
J Neurosurg; 1992 Nov; 77(5):778-82. PubMed ID: 1403122
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of nimustine, cytosine arabinoside, and methotrexate in cerebrospinal fluid during cerebrospinal fluid perfusion chemotherapy.
Morikawa N; Mori T; Kawashima H; Takeyama M; Abe T; Kobayashi H
Biol Pharm Bull; 2001 Apr; 24(4):436-8. PubMed ID: 11305611
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity and pharmacokinetics of ventriculolumbar perfusion of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in dogs.
Kochi M; Takaki S; Kuratsu J; Seto H; Kitamura I; Ushio Y
J Neurooncol; 1994; 19(3):239-44. PubMed ID: 7807174
[TBL] [Abstract][Full Text] [Related]
17. Intrathecal chemotherapy with ACNU for meningeal gliomatosis.
Yoshida TK; Beuls E; Shimizu K; Koulousakis A; Sturm V
Br J Cancer; 1992 Dec; 66(6):999-1004. PubMed ID: 1457369
[TBL] [Abstract][Full Text] [Related]
18. Intrathecal chemotherapy for refractory disseminated medulloblastoma.
Yoshimura J; Nishiyama K; Mori H; Takahashi H; Fujii Y
Childs Nerv Syst; 2008 May; 24(5):581-5. PubMed ID: 18057943
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal ACNU--a new therapeutic approach against malignant leptomeningeal tumors.
Arita N; Ushio Y; Hayakawa T; Nagatani M; Huang TY; Izumoto S; Mogami H
J Neurooncol; 1988 Nov; 6(3):221-6. PubMed ID: 3225641
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis.
Fleischhack G; Jaehde U; Bode U
Clin Pharmacokinet; 2005; 44(1):1-31. PubMed ID: 15634030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
